BRIEF published on 03/17/2026 at 07:08, 6 days ago Sartorius Stedim Biotech refines its strategy and aims for ambitious growth EBITDA Sartorius Stedim Biotech Product Portfolio Growth Objectives Biopharmaceutical Strategy
BRIEF published on 03/17/2026 at 07:08, 6 days ago Sartorius Stedim Biotech Sets New Growth Targets with Biopharma Focus Advanced Therapies Market Expansion Growth Targets Biopharma Strategy Bioprocessing Technologies
PRESS RELEASE published on 03/17/2026 at 07:03, 6 days ago Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius Stedim Biotech sharpens focus on biopharma with new growth targets and strategic initiatives to drive above-market growth and margin expansion Sartorius Stedim Biotech Strategic Initiatives Growth Targets Biopharma Above-market Growth
BRIEF published on 03/02/2026 at 16:30, 20 days 14 hours ago Sartorius Stedim Biotech: Statement on Share Capital Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
BRIEF published on 03/02/2026 at 16:30, 20 days 14 hours ago Sartorius Stedim Biotech: Share Capital and Voting Rights Update Share Capital Voting Rights French Commercial Code Sartorius Stedim Biotech EQS News Service
PRESS RELEASE published on 03/02/2026 at 16:25, 20 days 14 hours ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of February 28, 2026 Voting Rights Capital Déclaration Shares Sartorius Stedim Biotech
PRESS RELEASE published on 02/16/2026 at 09:13, 1 month 6 days ago Sartorius Stedim Biotech releases Universal Registration Document 2025 Sartorius Stedim Biotech releases Universal Registration Document 2025, providing insights into its financial performance and strategic outlook for the future Financial Report Sartorius Stedim Biotech Annual Results Universal Registration Document Biopharma Industry
BRIEF published on 02/16/2026 at 09:13, 1 month 6 days ago Sartorius Stedim Biotech publishes its 2025 Universal Registration Document Consolidated Financial Statements Sartorius Stedim Biotech Universal Registration Document Fiscal Year 2025 2026 Objectives
BRIEF published on 02/16/2026 at 09:13, 1 month 6 days ago Sartorius Stedim Biotech Releases 2025 Universal Registration Document Global Operations Sartorius Stedim Biotech Universal Registration Document Biopharmaceutical Solutions 2025 Financials
PRESS RELEASE published on 02/16/2026 at 09:09, 1 month 6 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech releases Universal Registration Document 2025 with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Business Development Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document
Published on 03/23/2026 at 02:00, 5 hours 11 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 17 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 07:00, 11 minutes ago Sonova presents renewed strategy to expand market leadership with ambition to reach CHF 6 billion in revenue by FY 2030/31
Published on 03/23/2026 at 07:00, 11 minutes ago AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland AG, AEVIS VICTORIA’s hospitality branch demonstrates continued operational growth in 2025, supported by strong demand and improving operating performance
Published on 03/23/2026 at 06:47, 24 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/23/2026 at 03:35, 3 hours 36 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/20/2026 at 19:00, 2 days 12 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 12 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 2 days 14 hours ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 13 hours ago Filing of the 2025 Universal Registration Document
